Antidepressant effects of coumarins and their derivatives: A critical analysis of research advances.


Journal

European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354

Informations de publication

Date de publication:
05 Oct 2023
Historique:
received: 20 05 2023
revised: 04 07 2023
accepted: 01 08 2023
medline: 31 8 2023
pubmed: 6 8 2023
entrez: 5 8 2023
Statut: ppublish

Résumé

Coumarins and their derivatives are non-flavonoids polyphenols with diverse pharmacological activities including anti-depressant effects. This study systematically examines the antidepressant effects of coumarins and their derivatives in relation to time series of research progress in the pharmacological pathways, association with other diseases, toxicity and bibliometric analysis. The review was approached using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) coupled with R package involving Biblioshiny, a web interface for Bibliometrix analysis and VOSviewer software analytic tools. Literature searches were conducted in Scopus, Web of Science, and PubMed from the inception through January 21, 2023. Coumarins, depression, coumarin derivatives and treatment were the main search terms used which resulted in the inclusion of 46 eligible publications. Scopoletin, psoralen, 7-hydroxycoumarin, meranzin hydrate, osthole, esculetin/umbelliferone were the most studied coumarins with antidepressant effects. Coumarins and their derivatives exerted antidepressant effects with a stronger affinity for monoamine oxidase-B (MAO-B) inhibition and, their inhibitory effect via neurotransmitter pathway on MAO is well-studied. However, epigenetic modification, neuroendocrine, neurotrophic pathways are understudied. Recent research focuses on their antidepressant effects which targeted cytokines and fibromyalgia. There is a link between the gut microbiome, the brain, and depression; meranzin hydrate exerts an antidepressant activity by remodelling the gastrointestinal system. We established that empirical data on some coumarins and their derivatives to support their antidepressant effects are limited. Likewise, the safe dose range for several coumarins and their derivatives is yet to be fully determined.

Identifiants

pubmed: 37543158
pii: S0014-2999(23)00470-3
doi: 10.1016/j.ejphar.2023.175958
pii:
doi:

Substances chimiques

Monoamine Oxidase Inhibitors 0
Coumarins 0
Monoamine Oxidase EC 1.4.3.4
Antidepressive Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

175958

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest We hereby declare no conflict of interest with regards to this review. The NRF had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the chapter, or in the decision to publish the results.

Auteurs

Nneka Augustina Akwu (NA)

Indigenous Knowledge Systems Centre, Faculty of Natural and Agricultural Sciences, North-West University, Private Bag X2046, Mmabatho, 2790, South Africa; Preclinical Drug Development Platform, Faculty of Health Sciences, North-West University, Private Bag X6001, Potchefstroom, 2520, South Africa. Electronic address: 49584219@mynwu.ac.za.

Makhotso Lekhooa (M)

Preclinical Drug Development Platform, Faculty of Health Sciences, North-West University, Private Bag X6001, Potchefstroom, 2520, South Africa.

Dou Deqiang (D)

Liaoning University of Traditional Chinese Medicine, 77 Life one Road, DD port, Dalian Economic and Technical Development Zone, Dalian, 116600, China.

Adeyemi Oladapo Aremu (AO)

Indigenous Knowledge Systems Centre, Faculty of Natural and Agricultural Sciences, North-West University, Private Bag X2046, Mmabatho, 2790, South Africa; School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Private Bag X54001, Durban, 4000, South Africa. Electronic address: Oladapo.Aremu@nwu.ac.za.

Articles similaires

1.00
Humans Magnetic Resonance Imaging Brain Infant, Newborn Infant, Premature
alpha-Synuclein Humans Animals Mice Lewy Body Disease
1.00
Animals Mice Immunity, Innate Interneurons Synapses
Humans Molecular Chaperones Brain Protein Folding Mutation

Classifications MeSH